Longitudinal monitor of Jun N-terminal kinase pathway associated phosphatase reflects clinical efficacy to triple conventional disease-modifying anti-rheumatic drugs treatment in rheumatoid arthritis patients

Objective This study aimed to investigate the correlation of Jun N-terminal kinase pathway associated phosphatase (JKAP) with inflammation, disease activity, and clinical efficacy to triple conventional disease-modifying anti-rheumatic drugs (cDMARDs) in rheumatoid arthritis (RA) patients. Methods A...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Inflammopharmacology 2021-08, Vol.29 (4), p.1131-1138
Hauptverfasser:	Song, Dongming, Zhu, Xiaoxia, Wang, Fangming, Sun, Jian
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Allergology Antirheumatic Agents - pharmacology Antirheumatic Agents - therapeutic use Arthritis, Rheumatoid - diagnosis Arthritis, Rheumatoid - drug therapy Arthritis, Rheumatoid - enzymology Biomedical and Life Sciences Biomedicine Dermatology Drug Therapy, Combination Female Follow-Up Studies Gastroenterology Humans Immunology JNK Mitogen-Activated Protein Kinases - biosynthesis Longitudinal Studies Male Middle Aged Original Article Pharmacology/Toxicology Prospective Studies Rheumatology Signal Transduction - drug effects Signal Transduction - physiology Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!